Search

In Stock

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

DISEASE INDICATIONS: Thromboembolism

MANUFACTURER: Alexion Pharmaceuticals

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

$24,063.64

Clear
Compare
SKU:669721

Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Here is a comprehensive description of Andexxa:

1. Mechanism of Action: Andexxa functions as a recombinant, inactivated factor Xa molecule. Its primary mode of action is to bind and sequester factor Xa inhibitors circulating in the bloodstream, such as apixaban and rivaroxaban, which are commonly used anticoagulant medications. By neutralizing these inhibitors, Andexxa helps restore the natural blood coagulation process, allowing the blood to clot effectively.

2. Indications: Andexxa is indicated for use in adults who experience life-threatening or uncontrolled bleeding events while taking factor Xa inhibitor anticoagulants. These bleeding events may occur as a result of trauma, surgery, or other medical conditions.

3. Administration: Andexxa is administered intravenously (IV) by healthcare professionals. The specific dosage and duration of treatment will depend on the patient’s medical condition and the extent of their bleeding.

4. Clinical Efficacy: Clinical studies have demonstrated that Andexxa can rapidly and effectively reverse the anticoagulant effects of factor Xa inhibitors, thereby promoting hemostasis (blood clotting) in patients with life-threatening bleeding events.

5. Monitoring: Patients receiving Andexxa require close monitoring of their bleeding status and laboratory coagulation parameters to ensure that appropriate clotting is achieved.

6. Precautions: As with any medication, Andexxa has potential side effects and should be used under the guidance of a healthcare professional. It may interact with other medications or medical conditions, so a thorough medical history should be provided to the prescribing physician.

Andexxa plays a critical role in the management of patients on factor Xa inhibitor anticoagulants who experience severe bleeding complications. It provides healthcare professionals with a valuable tool to rapidly reverse the anticoagulant effects and improve the chances of controlling life-threatening bleeding events. Patients and healthcare providers should work together to determine the most appropriate treatment approach for individual cases, taking into consideration the potential benefits and risks associated with Andexxa.

Package

4 vials of 100 mg, 4 vials of 200 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Buy Ondexxya (andexanet alfa) Online

$16,421.35
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

Buy Accrufer (ferric maltol) Online

(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

Buy Feraccru (ferric maltol) Online

$162.85
(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.

Buy Adakveo (crizanlizumab) Online

$1,844.95
(0 Reviews)
DISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Novartis USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).

Buy Ultomiris (ravulizumab) Online

(0 Reviews)
MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Back to Top
Product has been added to your cart